Oxidative stress in Alzheimer disease
- PMID: 19372765
- PMCID: PMC2675154
- DOI: 10.4161/cam.3.1.7402
Oxidative stress in Alzheimer disease
Abstract
Alzheimer disease (AD) is a progressive dementia affecting a large proportion of the aging population. The histopathological changes in AD include neuronal cell death, formation of amyloid plaques and neurofibrillary tangles. There is also evidence that brain tissue in patients with AD is exposed to oxidative stress (e.g., protein oxidation, lipid oxidation, DNA oxidation and glycoxidation) during the course of the disease. Advanced glycation endproducts (AGEs) are present in amyloid plaques in AD, and its extracellular accumulation may be caused by an accelerated oxidation of glycated proteins. AGEs participate in neuronal death causing direct (chemical) and indirect (cellular) free radical production and consequently increase oxidative stress. The development of drugs for the treatment of AD that breaks the vicious cycles of oxidative stress and neurodegeneration offer new opportunities. These approaches include AGE-inhibitors, antioxidants and anti-inflammatory substances, which prevent free radical production.
Figures
Similar articles
-
Investigations on oxidative stress and therapeutical implications in dementia.Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 3:68-73. doi: 10.1007/pl00014177. Eur Arch Psychiatry Clin Neurosci. 1999. PMID: 10654103 Review.
-
Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts.J Neural Transm (Vienna). 1998;105(4-5):439-61. doi: 10.1007/s007020050069. J Neural Transm (Vienna). 1998. PMID: 9720973 Review.
-
Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease.Methods Mol Biol. 2010;610:419-34. doi: 10.1007/978-1-60327-029-8_25. Methods Mol Biol. 2010. PMID: 20013193 Free PMC article.
-
Histochemical accumulation of oxidative damage products is associated with Alzheimer-like pathology in the canine.Amyloid. 2004 Jun;11(2):90-100. doi: 10.1080/13506120412331285779. Amyloid. 2004. PMID: 15478464
-
Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer's disease--a target for neuroprotective treatment strategies?J Neural Transm Suppl. 2002;(62):303-7. doi: 10.1007/978-3-7091-6139-5_28. J Neural Transm Suppl. 2002. PMID: 12456073 Review.
Cited by
-
Effectiveness and mechanisms of combined use of antioxidant nutrients in protecting against oxidative stress-induced neuronal loss and related neurological deficits.CNS Neurosci Ther. 2024 Jul;30(7):e14886. doi: 10.1111/cns.14886. CNS Neurosci Ther. 2024. PMID: 39072940 Free PMC article.
-
Comparative Metabolomics and Network Pharmacology Analysis Reveal Shared Neuroprotective Mechanisms of Bacopa monnieri (L.) Wettst and Centella asiatica (L.) Urb.Mol Neurobiol. 2024 May 30. doi: 10.1007/s12035-024-04223-3. Online ahead of print. Mol Neurobiol. 2024. PMID: 38814535
-
Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer's Disease.Mol Neurobiol. 2024 May 29. doi: 10.1007/s12035-024-04256-8. Online ahead of print. Mol Neurobiol. 2024. PMID: 38809370 Review.
-
Transcriptional Responses of Different Brain Cell Types to Oxygen Decline.Brain Sci. 2024 Mar 30;14(4):341. doi: 10.3390/brainsci14040341. Brain Sci. 2024. PMID: 38671993 Free PMC article.
-
Protective roles of peroxiporins AQP0 and AQP11 in human astrocyte and neuronal cell lines in response to oxidative and inflammatory stressors.Biosci Rep. 2024 Mar 29;44(3):BSR20231725. doi: 10.1042/BSR20231725. Biosci Rep. 2024. PMID: 38451099 Free PMC article.
References
-
- Gsell W, Strein I, Riederer P. The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared. J Neural Transm. 1996;47:73–101. - PubMed
-
- Gsell W, Strein I, Krause U, Riederer P. Neurochemical abnormalities in Alzheimer's disease and Parkinson's disease—a comparative review. J Neural Transm. 1997;51:145–159. - PubMed
-
- Retz W, Gsell W, Münch G, Rosler M, Riederer P. Free radicals in Alzheimer's disease. J Neural Transm. 1998;54:221–236. - PubMed
-
- Rösler M, Retz W, Thome J, Riederer P. Free radicals in Alzheimer's dementia: currently available therapeutic strategies. J Neural Transm. 1998;54:211–219. - PubMed
-
- Durany N, Münch G, Michel T, Riederer P. Investigations on oxidative stress and therapeutical implications in dementia. Eur Arch Psychiatry Clin Neurosci. 1999;249:68–73. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical